Asset profile
Nab-paclitaxel
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: HR+/HER2- Metastatic Breast Cancer, Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
116 competitors in this universe: 0 direct rivals (same mechanism and indication), 0 same-class, 116 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Nab-Paclitaxel: this drug | Approved | Small molecule | Microtubules | ||
| Abemaciclib (Verzenio) | Approved | Small molecule | CDK4 and CDK6 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alpelisib (BYL719) | Approved | Small molecule | PI3K-alpha | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET | ||
| Anastrozole | Approved | Small molecule | Aromatase | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| BAT1706 (Avzivi) | Approved | Monoclonal antibody | VEGF-A | ||
| BAY2927088 (Hyrnuo) | Approved | Small molecule | HER2 (ERBB2) exon 20 insertions and point mutations; also mutant-selective EGFR | ||
| Bevacizumab | Approved | Monoclonal antibody | VEGF-A, Vascular Endothelial Growth Factor Inhibitor | ||
| Bevacizumab-Awwb (MVASI) | Approved | Monoclonal antibody | VEGF-A | ||
| Binimetinib | Approved | Small molecule | MEK1/2 | ||
| Brigatinib | Approved | Small molecule | ALK | ||
| Capecitabine | Approved | Small molecule | Fluoropyrimidine (antimetabolite) |
…and 101 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(268 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (36)
October 2026 (8)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-09 · NCT06447662 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2026-10-19 · NCT05852691 · CT.gov ↗
What to watch
Phase 2Breast Cancer, Triple-negative Breast Cancer, Nab-paclitaxelRecruiting
Est. primary completion 2026-10-20 · NCT04138719 · CT.gov ↗
What to watch
Phase 1/2TNBCActive not recruiting
Est. primary completion 2026-10-30 · NCT05918133 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer UnresectableRecruiting
Est. primary completion 2026-10-30 · NCT06591650 · CT.gov ↗
What to watch
Phase 1Advanced Gastrointestinal, Biliary Tract, and Pancreatic CancersActive not recruiting
Est. primary completion 2026-10-31 · NCT06360354 · CT.gov ↗
What to watch
Phase 2Tongue Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2026-10-31 · NCT07346807 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-10-31 · NCT07647094 · CT.gov ↗
What to watch
November 2026 (4)
Phase 2Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-11-01 · NCT06122493 · CT.gov ↗
What to watch
Phase 2Head & Neck CancerRecruiting
Est. primary completion 2026-11-15 · NCT07353723 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-11-30 · NCT06725498 · CT.gov ↗
What to watch
December 2026 (24)
Phase 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy …Active not recruiting
Est. primary completion 2026-12 · NCT02207465 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2026-12 · NCT02340117 · CT.gov ↗
What to watch
Phase 2Unresectable Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12 · NCT02632305 · CT.gov ↗
What to watch
Phase 3Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer …Recruiting
Est. primary completion 2026-12 · NCT05281471 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast Cancer, Bone MetastasesRecruiting
Est. primary completion 2026-12 · NCT06538896 · CT.gov ↗
What to watch
Phase 3Triple-Negative Breast Cancer (TNBC)Recruiting
Est. primary completion 2026-12 · NCT06767527 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2026-12-15 · NCT07245797 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-17 · NCT06747169 · CT.gov ↗
What to watch
Phase 2Head and Neck CancerNot yet recruiting
Est. primary completion 2026-12-20 · NCT06793761 · CT.gov ↗
What to watch
Phase 2Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2026-12-30 · NCT03606967 · CT.gov ↗
What to watch
Phase 2Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast CancerActive not recruiting
Est. primary completion 2026-12-30 · NCT05227664 · CT.gov ↗
What to watch
Phase 2Locally Advanced Cervical CancerRecruiting
Est. primary completion 2026-12-30 · NCT06055738 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2026-12-30 · NCT06646055 · CT.gov ↗
What to watch
Phase 2Ureteral Cancer, Neoadjuvant Therapy, PD-1 Inhibitor, Kidney-sparing, Tislelizumab, Nab-paclitaxelRecruiting
Est. primary completion 2026-12-30 · NCT07125547 · CT.gov ↗
What to watch
Phase 2Upper Tract Urothelial Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor, Nab-paclitaxelRecruiting
Est. primary completion 2026-12-30 · NCT07126119 · CT.gov ↗
What to watch
Phase 2Renal Pelvic Carcinoma, Tislelizumab, PD-1 Inhibitor, Kidney-sparing, Nab-paclitaxelRecruiting
Est. primary completion 2026-12-30 · NCT07233252 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced Pancreatic CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT03652428 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8Active not recruiting
Est. primary completion 2026-12-31 · NCT04115163 · CT.gov ↗
What to watch
Phase 1/2Glioblastoma, Gliosarcoma, GBM, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype, Recurrent GlioblastomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04528680 · CT.gov ↗
What to watch
Early phase / not applicablePancreatic Cancer, Proton TherapyRecruiting
Est. primary completion 2026-12-31 · NCT04894643 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer MetastaticRecruiting
Est. primary completion 2026-12-31 · NCT05969171 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastro-esophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06808971 · CT.gov ↗
What to watch
Phase 1Peritoneal (Metastatic) CancerNot yet recruiting
Est. primary completion 2026-12-31 · NCT07454031 · CT.gov ↗
What to watch
2027 (114)
January 2027 (6)
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2027-01 · NCT05827055 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-01 · NCT06741644 · CT.gov ↗
What to watch
Phase 2Advanced Pancreatic CancersRecruiting
Est. primary completion 2027-01 · NCT06770439 · CT.gov ↗
What to watch
Phase 2Advanced Urothelial Carcinoma, Probiotics, ImmunotherapyRecruiting
Est. primary completion 2027-01-01 · NCT06904573 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-01-10 · NCT06345599 · CT.gov ↗
What to watch
Phase 2TNBCEnrolling by invitation
Est. primary completion 2027-01-15 · NCT07376629 · CT.gov ↗
What to watch
February 2027 (8)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT06463665 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer, PDAC, Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2027-02-01 · NCT05355298 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CarcinomaRecruiting
Est. primary completion 2027-02-01 · NCT06770452 · CT.gov ↗
What to watch
Phase 1Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma, Metastatic Hepatocellular Carcinoma …Active not recruiting
Est. primary completion 2027-02-02 · NCT05075993 · CT.gov ↗
What to watch
Phase 1Pancreas CancerActive not recruiting
Est. primary completion 2027-02-02 · NCT05497778 · CT.gov ↗
What to watch
Phase 2Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast CarcinomaRecruiting
Est. primary completion 2027-02-12 · NCT06492759 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-02-25 · NCT07452601 · CT.gov ↗
What to watch
Phase 2Gastric Cancer, Gastroesophageal-junction CancerRecruiting
Est. primary completion 2027-02-28 · NCT05687357 · CT.gov ↗
What to watch
March 2027 (6)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-03 · NCT03893955 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-03 · NCT06861894 · CT.gov ↗
What to watch
Phase 1Advanced Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-03 · NCT07348107 · CT.gov ↗
What to watch
Phase 1Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast Carcinoma …Recruiting
Est. primary completion 2027-03-31 · NCT05422794 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-03-31 · NCT06632405 · CT.gov ↗
What to watch
Phase 1/2Advanced Pancreatic Cancer, Ductal Adenocarcinoma of PancreasActive not recruiting
Est. primary completion 2027-03-31 · NCT07777211 · CT.gov ↗
What to watch
April 2027 (4)
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2027-04-01 · NCT07751055 · CT.gov ↗
What to watch
Phase 3Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, PembrolizumabRecruiting
Est. primary completion 2027-04-30 · NCT06102395 · CT.gov ↗
What to watch
Phase 2Gastric CancerNot yet recruiting
Est. primary completion 2027-04-30 · NCT06349967 · CT.gov ↗
What to watch
Phase 2Second-Line Therapy for Unresectable or Metastatic Biliary Tract CancerRecruiting
Est. primary completion 2027-04-30 · NCT07530445 · CT.gov ↗
What to watch
May 2027 (9)
Phase 1/2Solid TumorNot yet recruiting
Est. primary completion 2027-05-01 · NCT06939270 · CT.gov ↗
What to watch
Phase 2Gallbladder Cancer UnresectableEnrolling by invitation
Est. primary completion 2027-05-01 · NCT07310069 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerRecruiting
Est. primary completion 2027-05-14 · NCT06953999 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerRecruiting
Est. primary completion 2027-05-15 · NCT06951997 · CT.gov ↗
What to watch
Phase 2Angiosarcoma MetastaticRecruiting
Est. primary completion 2027-05-20 · NCT04859465 · CT.gov ↗
What to watch
Phase 2Lung CancerRecruiting
Est. primary completion 2027-05-30 · NCT06421298 · CT.gov ↗
What to watch
Phase 2High-grade Serous Ovarian Cancer (HGSOC), Fallopian Tube Cancers, Primary Peritoneal CancerNot yet recruiting
Est. primary completion 2027-05-30 · NCT07432594 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-05-30 · NCT07618910 · CT.gov ↗
What to watch
Phase 2HER2-positive Breast CancerNot yet recruiting
Est. primary completion 2027-05-31 · NCT06973525 · CT.gov ↗
What to watch
June 2027 (12)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT04999761 · CT.gov ↗
What to watch
Phase 2Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-06 · NCT05825066 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06922591 · CT.gov ↗
What to watch
Phase 2Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid NeoplasmRecruiting
Est. primary completion 2027-06-01 · NCT03907475 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-06-01 · NCT06975475 · CT.gov ↗
What to watch
Phase 4HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-06-10 · NCT05420454 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2027-06-20 · NCT07163273 · CT.gov ↗
What to watch
Phase 1/2Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Pancreatic CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT04396821 · CT.gov ↗
What to watch
Phase 2Metastatic Head-and-neck Squamous-cell CarcinomaActive not recruiting
Est. primary completion 2027-06-30 · NCT04831320 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-06-30 · NCT06182072 · CT.gov ↗
What to watch
Phase 1/2Pancreatic CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT06513455 · CT.gov ↗
What to watch
Phase 2Biliary Tract NeoplasmsRecruiting
Est. primary completion 2027-06-30 · NCT07668453 · CT.gov ↗
What to watch
July 2027 (9)
Phase 2Pancreatic Cancer, Metastatic AdenocarcinomaRecruiting
Est. primary completion 2027-07 · NCT05776524 · CT.gov ↗
What to watch
Phase 3Triple Negative Breast Cancer(TNBC)Active not recruiting
Est. primary completion 2027-07 · NCT06419621 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-07 · NCT06576115 · CT.gov ↗
What to watch
Phase 2Cervical CarcinomaNot yet recruiting
Est. primary completion 2027-07 · NCT07088731 · CT.gov ↗
What to watch
Phase 4HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-07-10 · NCT05420467 · CT.gov ↗
What to watch
Phase 2Gastric CancerRecruiting
Est. primary completion 2027-07-10 · NCT06791148 · CT.gov ↗
What to watch
Phase 2Gastric (Stomach) CancerNot yet recruiting
Est. primary completion 2027-07-25 · NCT06748508 · CT.gov ↗
What to watch
Phase 1/2Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic …Active not recruiting
Est. primary completion 2027-07-30 · NCT07280377 · CT.gov ↗
What to watch
Phase 2Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 …Active not recruiting
Est. primary completion 2027-07-31 · NCT03181100 · CT.gov ↗
What to watch
August 2027 (10)
Phase 1/2Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Basal Cell NeoplasmRecruiting
Est. primary completion 2027-08 · NCT06483555 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08 · NCT06917079 · CT.gov ↗
What to watch
Early phase / not applicableGastric Cancer, Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-08 · NCT07139587 · CT.gov ↗
What to watch
Phase 1/2Pancreatic CancerRecruiting
Est. primary completion 2027-08 · NCT07444541 · CT.gov ↗
What to watch
Phase 2Esophagus CancerNot yet recruiting
Est. primary completion 2027-08-01 · NCT07046221 · CT.gov ↗
What to watch
Phase 1TNBC, Triple Negative Breast CancerRecruiting
Est. primary completion 2027-08-01 · NCT07178171 · CT.gov ↗
What to watch
Phase 1/2Pancreas Cancer, Metastatic, Pancreas Cancer, Stage IV, Ductal Adenocarcinoma of the PancreasRecruiting
Est. primary completion 2027-08-01 · NCT07701486 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08-10 · NCT07089199 · CT.gov ↗
What to watch
Phase 2Pancreatic Adenocarcinoma, Resectable Pancreatic CancerRecruiting
Est. primary completion 2027-08-29 · NCT05624918 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2027-08-31 · NCT06423326 · CT.gov ↗
What to watch
September 2027 (11)
Early phase / not applicableHR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2027-09 · NCT05287308 · CT.gov ↗
What to watch
Phase 2Adenocarcinoma, Carcinoma, Pancreatic DuctalRecruiting
Est. primary completion 2027-09 · NCT07259317 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-09-01 · NCT04253964 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast CancerRecruiting
Est. primary completion 2027-09-10 · NCT05192798 · CT.gov ↗
What to watch
Phase 2TNBC, Triple Negative Breast CancerRecruiting
Est. primary completion 2027-09-15 · NCT07601178 · CT.gov ↗
What to watch
Phase 2Head and Neck Cancer Squamous Cell Carcinoma, Skull Base--Cancer, Neoadjuvant Chemoimmunotherapy, Objective Response RateNot yet recruiting
Est. primary completion 2027-09-20 · NCT07145931 · CT.gov ↗
What to watch
Phase 2Hepatoid Adenocarcinoma of StomachRecruiting
Est. primary completion 2027-09-20 · NCT07178340 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT06532331 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic CancerNot yet recruiting
Est. primary completion 2027-09-30 · NCT06662669 · CT.gov ↗
What to watch
Phase 2Neoadjuvant Treatment for Locally Advanced Cervical CancerRecruiting
Est. primary completion 2027-09-30 · NCT07286253 · CT.gov ↗
What to watch
Phase 1Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2027-09-30 · NCT07317609 · CT.gov ↗
What to watch
October 2027 (8)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10 · NCT06561685 · CT.gov ↗
What to watch
Phase 1/2Locally Advanced or Metastatic Pancreatic Cancer WithRecruiting
Est. primary completion 2027-10 · NCT07296341 · CT.gov ↗
What to watch
Phase 2Locally Advanced Pancreatic Cancer With KRAS G12D MutationRecruiting
Est. primary completion 2027-10 · NCT07438106 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB, Pancreatic Cancer Stage IIINot yet recruiting
Est. primary completion 2027-10-01 · NCT05562297 · CT.gov ↗
What to watch
Phase 2Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-10-30 · NCT04940286 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerActive not recruiting
Est. primary completion 2027-10-31 · NCT04266249 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-10-31 · NCT06604351 · CT.gov ↗
What to watch
November 2027 (4)
Phase 1/2Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS MutationNot yet recruiting
Est. primary completion 2027-11 · NCT07678593 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-11-30 · NCT04297605 · CT.gov ↗
What to watch
Phase 2Hypopharyngeal CarcinomaRecruiting
Est. primary completion 2027-11-30 · NCT07248956 · CT.gov ↗
What to watch
Phase 2Ovarian Cancer, Immunotherapy, PembrolizumabRecruiting
Est. primary completion 2027-11-30 · NCT07261683 · CT.gov ↗
What to watch
December 2027 (27)
Phase 2Phase II, Open-label, Parallel 2-arm, Multi-centerActive not recruiting
Est. primary completion 2027-12 · NCT05026905 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT05431270 · CT.gov ↗
What to watch
Phase 1/2Gastric or Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC), Colorectal CancerRecruiting
Est. primary completion 2027-12 · NCT05482893 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast Cancer MetastaticRecruiting
Est. primary completion 2027-12 · NCT05582538 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-12 · NCT06639724 · CT.gov ↗
What to watch
Phase 2Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2027-12 · NCT07255404 · CT.gov ↗
What to watch
Phase 2Muscle Invasive Bladder Cancer (MIBC)Recruiting
Est. primary completion 2027-12 · NCT07296705 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT07200947 · CT.gov ↗
What to watch
Phase 2SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT07307443 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Neoadjuvant TherapyNot yet recruiting
Est. primary completion 2027-12-30 · NCT06177522 · CT.gov ↗
What to watch
Phase 2Gastric (Cardia, Body) Cancer, Stomach Adenocarcinoma, Locally AdvancedNot yet recruiting
Est. primary completion 2027-12-30 · NCT07018063 · CT.gov ↗
What to watch
Phase 1Adenocarcinoma PancreasRecruiting
Est. primary completion 2027-12-30 · NCT07253662 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerNot yet recruiting
Est. primary completion 2027-12-30 · NCT07272109 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2027-12-31 · NCT04683315 · CT.gov ↗
What to watch
Phase 2Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT05083247 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT05582499 · CT.gov ↗
What to watch
Phase 1Metastatic Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2027-12-31 · NCT06229496 · CT.gov ↗
What to watch
Phase 2Cholangiocarcinoma ResectableNot yet recruiting
Est. primary completion 2027-12-31 · NCT06569225 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Advanced Triple Negative Breast CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT06849492 · CT.gov ↗
What to watch
Phase 2Esophageal Cancer (EsC)Recruiting
Est. primary completion 2027-12-31 · NCT06869213 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT06964906 · CT.gov ↗
What to watch
Phase 2Lung Cancer (SCLC)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07258147 · CT.gov ↗
What to watch
Phase 1/2Triple Negative Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT07281976 · CT.gov ↗
What to watch
Phase 2/3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2027-12-31 · NCT07410169 · CT.gov ↗
What to watch
Phase 1/2Borderline Resectable Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07705919 · CT.gov ↗
What to watch
Phase 2Esophageal CancerRecruiting
Est. primary completion 2027-12-31 · NCT07733830 · CT.gov ↗
What to watch
2028 (55)
January 2028 (6)
Phase 1/2Solid CancerActive not recruiting
Est. primary completion 2028-01-01 · NCT06771622 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC)Not yet recruiting
Est. primary completion 2028-01-01 · NCT07547332 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2028-01-01 · NCT07595770 · CT.gov ↗
What to watch
Phase 1Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-01-31 · NCT07024615 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-01-31 · NCT07284836 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2028-01-31 · NCT07678580 · CT.gov ↗
What to watch
February 2028 (1)
Phase 1Unresectable or Metastatic Advanced Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-02 · NCT06393400 · CT.gov ↗
What to watch
March 2028 (1)
Phase 2CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-03-31 · NCT07483554 · CT.gov ↗
What to watch
April 2028 (1)
Phase 2Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Head & Neck Cancer, Neoadjuvant TherapyRecruiting
Est. primary completion 2028-04-30 · NCT07601737 · CT.gov ↗
What to watch
May 2028 (4)
Phase 2Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic AdenocarcinomaRecruiting
Est. primary completion 2028-05 · NCT07076212 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Active not recruiting
Est. primary completion 2028-05-30 · NCT07682376 · CT.gov ↗
What to watch
Phase 2/3Metastatic Pancreatic CancerRecruiting
Est. primary completion 2028-05-31 · NCT06361888 · CT.gov ↗
What to watch
Phase 2ESCCNot yet recruiting
Est. primary completion 2028-05-31 · NCT07493993 · CT.gov ↗
What to watch
June 2028 (11)
Phase 2Pancreatic Cancer, Adenocarcinoma of the Pancreas, AdenocarcinomaActive not recruiting
Est. primary completion 2028-06 · NCT04543071 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-06 · NCT05502237 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-06 · NCT05786924 · CT.gov ↗
What to watch
Phase 2Breast Cancer, HER2-positive Breast CancerRecruiting
Est. primary completion 2028-06 · NCT06441890 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC) …Recruiting
Est. primary completion 2028-06 · NCT07491445 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-06-15 · NCT07845786 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting
Est. primary completion 2028-06-22 · NCT07235202 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerActive not recruiting
Est. primary completion 2028-06-29 · NCT04241276 · CT.gov ↗
What to watch
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2028-06-30 · NCT07057427 · CT.gov ↗
What to watch
Phase 2QL1706, ESCC, First-line TherapyNot yet recruiting
Est. primary completion 2028-06-30 · NCT07533305 · CT.gov ↗
What to watch
Phase 2Gallbladder CancerNot yet recruiting
Est. primary completion 2028-06-30 · NCT07767994 · CT.gov ↗
What to watch
July 2028 (3)
Phase 2Pancreas AdenocarcinomaRecruiting
Est. primary completion 2028-07-01 · NCT07043270 · CT.gov ↗
What to watch
Phase 2Salivary Gland Carcinoma, Precision TherapyRecruiting
Est. primary completion 2028-07-10 · NCT06145308 · CT.gov ↗
What to watch
Phase 2Triple-Negative Breast Cancer (TNBC)Not yet recruiting
Est. primary completion 2028-07-30 · NCT07752550 · CT.gov ↗
What to watch
August 2028 (3)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-08-01 · NCT05800587 · CT.gov ↗
What to watch
Phase 2Solid TumorsRecruiting
Est. primary completion 2028-08-15 · NCT07492680 · CT.gov ↗
What to watch
Phase 2Head and Neck Cancer Squamous Cell CarcinomaRecruiting
Est. primary completion 2028-08-30 · NCT07457346 · CT.gov ↗
What to watch
September 2028 (7)
Phase 2Metastatic Squamous Non-Small Cell Lung CarcinomaRecruiting
Est. primary completion 2028-09 · NCT05613413 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09 · NCT07049055 · CT.gov ↗
What to watch
Phase 1/2Advan'ce'd, AdvancedNot yet recruiting
Est. primary completion 2028-09 · NCT07361991 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, AdultRecruiting
Est. primary completion 2028-09 · NCT07436741 · CT.gov ↗
What to watch
Phase 1/2Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC, Gastrointestinal Cancer, Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09-30 · NCT06445062 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2028-09-30 · NCT06904378 · CT.gov ↗
What to watch
Phase 2ORR,OS,PFSNot yet recruiting
Est. primary completion 2028-09-30 · NCT07328802 · CT.gov ↗
What to watch
October 2028 (4)
Phase 3Head and Neck Squamous Cell CarcinomasRecruiting
Est. primary completion 2028-10 · NCT05582265 · CT.gov ↗
What to watch
Phase 1Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum …Recruiting
Est. primary completion 2028-10-11 · NCT05285358 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-10-13 · NCT07223047 · CT.gov ↗
What to watch
Phase 2Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (OPSCC)Not yet recruiting
Est. primary completion 2028-10-31 · NCT07812467 · CT.gov ↗
What to watch
November 2028 (1)
Phase 2Esophageal Squamous CarcinomaNot yet recruiting
Est. primary completion 2028-11-30 · NCT07490002 · CT.gov ↗
What to watch
December 2028 (13)
Phase 2/3Biliary Tract Cancer, CholangiocarcinomaRecruiting
Est. primary completion 2028-12 · NCT06037980 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12 · NCT07020221 · CT.gov ↗
What to watch
Phase 3Pancreatic CancerRecruiting
Est. primary completion 2028-12 · NCT07079228 · CT.gov ↗
What to watch
Phase 2Acral Melanoma, Mucosal MelanomaNot yet recruiting
Est. primary completion 2028-12 · NCT07347444 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12 · NCT07475234 · CT.gov ↗
What to watch
Phase 2Head and Neck CancersNot yet recruiting
Est. primary completion 2028-12-01 · NCT06894459 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8Recruiting
Est. primary completion 2028-12-01 · NCT07226856 · CT.gov ↗
What to watch
Phase 3Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC) …Recruiting
Est. primary completion 2028-12-30 · NCT07621718 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2028-12-31 · NCT05382559 · CT.gov ↗
What to watch
Phase 2HER2-positive Early Breast CancerRecruiting
Est. primary completion 2028-12-31 · NCT07340398 · CT.gov ↗
What to watch
Phase 2Gastric AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12-31 · NCT07610629 · CT.gov ↗
What to watch
Phase 2Late-stage Resectable Esophageal Squamous CarcinomaRecruiting
Est. primary completion 2028-12-31 · NCT07622797 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Active not recruiting
Est. primary completion 2028-12-31 · NCT07711470 · CT.gov ↗
What to watch
2029 (30)
January 2029 (4)
Phase 3Pancreatic Adenocarcinoma Advanced or MetastaticRecruiting
Est. primary completion 2029-01-01 · NCT06897644 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-01-12 · NCT06422143 · CT.gov ↗
What to watch
Phase 1Clinical Stage IVB Gastric Cancer AJCC v8, Metastatic Gastric Adenocarcinoma, Metastatic Malignant Neoplasm in the PeritoneumRecruiting
Est. primary completion 2029-01-14 · NCT06675136 · CT.gov ↗
What to watch
Phase 2/3Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Carcinoma …Active not recruiting
Est. primary completion 2029-01-15 · NCT06115499 · CT.gov ↗
What to watch
February 2029 (2)
March 2029 (4)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-03 · NCT06586515 · CT.gov ↗
What to watch
Phase 1Pancreatic Adenocarcinoma MetastaticRecruiting
Est. primary completion 2029-03 · NCT07377045 · CT.gov ↗
What to watch
Phase 2/3Thymoma and Thymic CarcinomaNot yet recruiting
Est. primary completion 2029-03 · NCT07463313 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2029-03-25 · NCT06323369 · CT.gov ↗
What to watch
April 2029 (2)
May 2029 (4)
Early phase / not applicableNon-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-05 · NCT07538193 · CT.gov ↗
What to watch
Phase 1/2Pancreas Ductal Adenocarcinoma, Pancreas Cancer, Metastatic, Pancreatic Adenocarcinoma Metastatic, Adenosquamous Carcinoma of the Pancreas …Not yet recruiting
Est. primary completion 2029-05 · NCT07665684 · CT.gov ↗
What to watch
Phase 2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2029-05-01 · NCT07527806 · CT.gov ↗
What to watch
Phase 2/3Pancreatic Ductal AdenocarcinomaActive not recruiting
Est. primary completion 2029-05-03 · NCT07076121 · CT.gov ↗
What to watch
June 2029 (1)
Phase 2Locally Advanced, ResectableActive not recruiting
Est. primary completion 2029-06-20 · NCT07374003 · CT.gov ↗
What to watch
July 2029 (3)
Phase 2Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8, Metastatic Malignant Neoplasm in the PeritoneumRecruiting
Est. primary completion 2029-07 · NCT04858009 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-07-02 · NCT07221474 · CT.gov ↗
What to watch
Phase 2/3Gall Bladder CancerRecruiting
Est. primary completion 2029-07-21 · NCT06214572 · CT.gov ↗
What to watch
August 2029 (1)
Phase 1/2HR+/HER2- Metastatic Breast CancerNot yet recruiting
Est. primary completion 2029-08-01 · NCT07738341 · CT.gov ↗
What to watch
September 2029 (4)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-09 · NCT07563738 · CT.gov ↗
What to watch
Phase 2/3Biliary Tract Cancer, Second Line Treatment, Chemotherapy, Tyrosine Kinase InhibitorNot yet recruiting
Est. primary completion 2029-09-01 · NCT06662877 · CT.gov ↗
What to watch
Phase 2Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2029-09-30 · NCT04892953 · CT.gov ↗
What to watch
Phase 3Squamous Cell Carcinoma of Head and NeckNot yet recruiting
Est. primary completion 2029-09-30 · NCT06647563 · CT.gov ↗
What to watch
October 2029 (1)
Phase 2Phase 2 Study, BMS-986504, MTAP-deleted Pancreatic CancerRecruiting
Est. primary completion 2029-10-01 · NCT07283705 · CT.gov ↗
What to watch
December 2029 (4)
Phase 3HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2029-12 · NCT07173751 · CT.gov ↗
What to watch
Phase 2Esophageal CancerRecruiting
Est. primary completion 2029-12-31 · NCT06869226 · CT.gov ↗
What to watch
Phase 3Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 …Recruiting
Est. primary completion 2029-12-31 · NCT06998940 · CT.gov ↗
What to watch
Phase 1/2Metastatic Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2029-12-31 · NCT07640295 · CT.gov ↗
What to watch
2030 (18)
January 2030 (3)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-01 · NCT06607185 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-01 · NCT06745882 · CT.gov ↗
What to watch
Phase 2/3Double BlindRecruiting
Est. primary completion 2030-01-24 · NCT07662395 · CT.gov ↗
What to watch
February 2030 (1)
Phase 2Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal AdenocarcinomaNot yet recruiting
Est. primary completion 2030-02-03 · NCT07748611 · CT.gov ↗
What to watch
March 2030 (1)
Phase 2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2030-03-30 · NCT06439693 · CT.gov ↗
What to watch
April 2030 (1)
Phase 1/2Pancreatic Ductal AdenocarcinomaRecruiting
Est. primary completion 2030-04 · NCT05257993 · CT.gov ↗
What to watch
June 2030 (1)
Phase 3Pancreatic CancerNot yet recruiting
Est. primary completion 2030-06-30 · NCT07383922 · CT.gov ↗
What to watch
July 2030 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-07-01 · NCT06692738 · CT.gov ↗
What to watch
August 2030 (1)
Phase 3Pancreatic Cancer ResectableNot yet recruiting
Est. primary completion 2030-08-31 · NCT07155629 · CT.gov ↗
What to watch
September 2030 (2)
November 2030 (2)
December 2030 (5)
Phase 2Recurrent or Metastatic Cervical CancerNot yet recruiting
Est. primary completion 2030-12 · NCT07763496 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerActive not recruiting
Est. primary completion 2030-12-31 · NCT04589234 · CT.gov ↗
What to watch
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2030-12-31 · NCT05981014 · CT.gov ↗
What to watch
Phase 3Locally Advanced Oral Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma (OSCC)Recruiting
Est. primary completion 2030-12-31 · NCT07371611 · CT.gov ↗
What to watch
Phase 2HPV-Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Head and Neck CancerNot yet recruiting
Est. primary completion 2030-12-31 · NCT07628062 · CT.gov ↗
What to watch
2031 (9)
January 2031 (1)
Phase 2/3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2031-01 · NCT07318883 · CT.gov ↗
What to watch
March 2031 (2)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2031-03-01 · NCT05919537 · CT.gov ↗
What to watch
Phase 2/3Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant ChemoimmunotherapyRecruiting
Est. primary completion 2031-03-01 · NCT06288373 · CT.gov ↗
What to watch
May 2031 (1)
Phase 2/3Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2031-05 · NCT06861777 · CT.gov ↗
What to watch
June 2031 (1)
Phase 2/3Pancreatic Cancer, Advanced or Metastatic, BRCA1/2 Mutation, PALB2 Gene MutationActive not recruiting
Est. primary completion 2031-06-02 · NCT06783140 · CT.gov ↗
What to watch
August 2031 (2)
October 2031 (1)
Phase 3Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8Recruiting
Est. primary completion 2031-10-15 · NCT05624996 · CT.gov ↗
What to watch
December 2031 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2031-12-01 · NCT06837948 · CT.gov ↗
What to watch
2032 (3)
March 2032 (1)
Phase 3Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2032-03-15 · NCT07629817 · CT.gov ↗
What to watch
April 2032 (1)
Phase 1/2HR+/HER2- Metastatic Breast CancerRecruiting
Est. primary completion 2032-04-30 · NCT05981001 · CT.gov ↗
What to watch
December 2032 (1)
Phase 3Locally Advanced Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Carcinoma, Pancreas Cancer, Neoadjuvant Chemotherapy, Surgery …Recruiting
Est. primary completion 2032-12-31 · NCT06714604 · CT.gov ↗
What to watch
2033 (1)
July 2033 (1)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2033-07 · NCT04198766 · CT.gov ↗
What to watch
2035 (1)
December 2035 (1)
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2035-12-31 · NCT07365319 · CT.gov ↗
What to watch
2039 (1)
April 2039 (1)
Phase 3Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2039-04-01 · NCT06096844 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.